Loading...
UOM logo

AS Latvijas Juras medicinas centrsMUN:UOM Stock Report

Market Cap €6.7m
Share Price
€8.40
n/a
1Y25.4%
7D31.3%
Portfolio Value
View

AS Latvijas Juras medicinas centrs

MUN:UOM Stock Report

Market Cap: €6.7m

AS Latvijas Juras medicinas centrs (UOM) Stock Overview

Provides health care services in the Republic of Latvia. More details

UOM fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends2/6

UOM Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

AS Latvijas Juras medicinas centrs Competitors

Price History & Performance

Summary of share price highs, lows and changes for AS Latvijas Juras medicinas centrs
Historical stock prices
Current Share Price€8.40
52 Week High€8.40
52 Week Low€6.00
Beta-0.063
1 Month Change31.25%
3 Month Change31.25%
1 Year Change25.37%
3 Year Change-29.41%
5 Year Change33.33%
Change since IPO833.33%

Recent News & Updates

AS Latvijas Juras medicinas centrs (MUN:UOM) Looks Just Right With A 31% Price Jump

Dec 06
AS Latvijas Juras medicinas centrs (MUN:UOM) Looks Just Right With A 31% Price Jump

Recent updates

AS Latvijas Juras medicinas centrs (MUN:UOM) Looks Just Right With A 31% Price Jump

Dec 06
AS Latvijas Juras medicinas centrs (MUN:UOM) Looks Just Right With A 31% Price Jump

AS Latvijas Juras medicinas centrs' (MUN:UOM) Dividend Will Be Increased To €0.20

Jun 23
AS Latvijas Juras medicinas centrs' (MUN:UOM) Dividend Will Be Increased To €0.20

Investors Shouldn't Be Too Comfortable With AS Latvijas Juras medicinas centrs' (MUN:UOM) Robust Earnings

Jun 06
Investors Shouldn't Be Too Comfortable With AS Latvijas Juras medicinas centrs' (MUN:UOM) Robust Earnings

A Look At The Intrinsic Value Of A/S Latvijas Juras medicinas centrs (MUN:UOM)

Jun 01
A Look At The Intrinsic Value Of A/S Latvijas Juras medicinas centrs (MUN:UOM)

Could A/S Latvijas Juras medicinas centrs (MUN:UOM) Have The Makings Of Another Dividend Aristocrat?

Feb 17
Could A/S Latvijas Juras medicinas centrs (MUN:UOM) Have The Makings Of Another Dividend Aristocrat?

Will Weakness in A/S Latvijas Juras medicinas centrs' (MUN:UOM) Stock Prove Temporary Given Strong Fundamentals?

Dec 24
Will Weakness in A/S Latvijas Juras medicinas centrs' (MUN:UOM) Stock Prove Temporary Given Strong Fundamentals?

Shareholder Returns

UOMDE HealthcareDE Market
7D31.3%1.0%1.8%
1Y25.4%18.0%10.0%

Return vs Industry: UOM exceeded the German Healthcare industry which returned 18.3% over the past year.

Return vs Market: UOM exceeded the German Market which returned 10.1% over the past year.

Price Volatility

Is UOM's price volatile compared to industry and market?
UOM volatility
UOM Average Weekly Movement5.7%
Healthcare Industry Average Movement4.7%
Market Average Movement5.0%
10% most volatile stocks in DE Market12.0%
10% least volatile stocks in DE Market2.5%

Stable Share Price: UOM has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: UOM's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1996364Janis Birkswww.ljmc.lv

AS Latvijas Juras medicinas centrs provides health care services in the Republic of Latvia. The company engages in the general and special medical practice, dental practice, human health, residential nursing care, residential care, social work, physical well-being, and other personal service activities. It also involved in provision of other education services related activities.

AS Latvijas Juras medicinas centrs Fundamentals Summary

How do AS Latvijas Juras medicinas centrs's earnings and revenue compare to its market cap?
UOM fundamental statistics
Market cap€6.72m
Earnings (TTM)€460.45k
Revenue (TTM)€10.39m
14.6x
P/E Ratio
0.6x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
UOM income statement (TTM)
Revenue€10.39m
Cost of Revenue€9.01m
Gross Profit€1.38m
Other Expenses€918.01k
Earnings€460.45k

Last Reported Earnings

Sep 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)0.58
Gross Margin13.27%
Net Profit Margin4.43%
Debt/Equity Ratio0%

How did UOM perform over the long term?

See historical performance and comparison

Dividends

1.2%
Current Dividend Yield
17%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/08 11:16
End of Day Share Price 2025/12/08 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

AS Latvijas Juras medicinas centrs is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.